K-312

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameK-312
Drug Alias NameK-312
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProprotein convertase subtilisin kexin type 9 inhibitorsCholesteryl ester transfer protein inhibitors
TargetsProprotein convertase subtilisin kexin type 9Cholesteryl ester transfer protein
Therapy Area/IndicationsHyperlipidemiasDyslipidemias
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesKowa Dental Health Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKowa Research Institute Inc
Active IndicationsN/A
Inactive IndicationsHyperlipidemiasDyslipidemias

Other Information

ATC CodeN/A
Related LinksN/A